Opinions
Opinions
| Date | Opinions | Topic |
|---|---|---|
| Jan 20, 2012 |
''Who Else Is Paying Your Doctor?'' "It took longer than expected, but the Obama administration is finally poised to enact badly needed regulations requiring that the manufacturers of drugs, medical devices and medical supplies disclose all payments they make to doctors or teaching hospitals." |
Conflicts of Interest |
| Dec 25, 2011 |
''Speed up work on payment disclosure'' "Two-and-a-half months after blowing a congressional deadline, federal officials have finally gotten around to rolling out the Physician Payments Sunshine Act -- a historic new law requiring medical device and pharmaceutical industries to disclose payments to doctors." |
Conflicts of Interest |
| Apr 19, 2010 |
''Shining new light on payments to docs'' "Buried deep within the massive health care overhaul passed by Congress are tough new laws that will soon shine a much-needed light on physicians' lucrative financial ties to industry. Known as the Physician Payments Sunshine provisions, these are some of the most significant, yet unheralded, reforms contained in the historic health care legislation signed by President Obama last month." |
Conflicts of Interest |
| Mar 7, 2009 |
''The withdrawal of drug-company money'' "In recent years, the pharmaceutical industry has been repeatedly (and rightly) excoriated for its shameless efforts to promote its products: Freebies handed out to doctors as inducements to prescribe particular drugs." |
Conflicts of Interest |
| Nov 3, 2008 |
''Let public see doctors’ ties to drug companies'' "What is the appropriate relationship between the medical profession and the drug industry? Last month, Dr. Charles Nemeroff stepped down as chair of Emory University’s psychiatry department after a Senate investigation exposed his failure to report hundreds of thousands of dollars in industry consulting and speaking fees, including payments from Glaxo-SmithKline, whose drug he was also studying using taxpayer dollars from the National Institutes of Health." |
Conflicts of Interest |
| Feb 28, 2008 |
''A line between docs and drugs'' "Both the drug industry and the teaching hospitals play essential roles in modern medicine, but their functions need to be kept separate, as they will be under a policy recently unveiled by UMass Memorial Medical Center in Worcester." |
Conflicts of Interest |
| May 7, 2013 |
''The Senate Aims to Clean Up Compounding Pharmacies'' When a doctor sticks a needle in you, you expect that the drugs it carries won’t be tainted. But, possibly owing to a strange gray area in federal law, thousands of patients last October got injections for back pain that contained highly dangerous fungal meningitis, and dozens of them died. Members of the Senate Health, Education, Labor and Pensions Committee are now seeking to fix the government’s oversight of the obscure world of compounding pharmacies. The reforms they want are overdue. |
Drug Manufacturing and Distribution, Drug Safety |
| Apr 4, 2013 |
''Crackdown Needed on Specialty Pharmacies'' "The deaths and illnesses linked last fall to a New England pharmacy operating in the regulatory shadows as a cut-rate drug manufacturer is one of the biggest pharmaceutical public health disasters in American history." |
Drug Manufacturing and Distribution, Drug Safety |
| Jul 1, 2012 |
''Next steps to thwart 'superbugs''' "An old saying goes, you don't miss your water till your well runs dry. When it comes to antibiotics, we're not only running out of water but there are no rain clouds on the horizon. The overuse and underdevelopment of these drugs have brought us close to the brink of a world without cures for deadly infections." |
Drug Manufacturing and Distribution, Antibiotic Innovation, Antibiotics in Food Animal Production |
| Nov 9, 2010 |
''FDA relies too much on tipoffs, not enough on drug checks'' "A drug-company whistle-blower last month pocketed $96 million -- her share of the money Medicare and Medicaid paid for tainted drugs. The fee is way too high -- employees will drop a dime for far less." |
Drug Manufacturing and Distribution, Drug Safety |
